Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NVE CORP /NEW/nvec · Entity 5507 | Director | August 06, 2020 | August 10, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NVE CORP /NEW/
Report date August 06, 2020 · Filed August 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $57.24 · Expires 2030-08-06 | Direct | 7,000 |
Reported balance
After 2020-08-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-08-06 · Grant · Acquired 1,000 · Balance 7,000 F1: Option granted automatically on Mr. Maharaj's reelection to NVE's Board of Directors |
Filing footnotes · ownership attribution and instrument terms
F1: Option granted automatically on Mr. Maharaj's reelection to NVE's Board of Directors
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SURMODICS INC
Report date November 19, 2025 · Filed November 19, 2025
Section 16 reporting ended · disclosed 2025-11-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-11-19 transaction · row 1
1 source rowRow 1 · 2025-11-19 · Disposition to issuer · Disposed 192,056 · Balance 0 F1: Pursuant to that certain Merger Agreement, dated as of May 28, 2024, by and among the Surmodics, Inc. (the "Issuer"), BCE Parent, LLC, ("Parent"), and BCE Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.05 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $43.00 per share in cash, without interest and subject to any applicable tax withholdings (the "Merger Consideration"). All outstanding restricted stock units ("RSUs") held by the reporting person vested immediately prior to the Effective Time and the reporting person is entitled to receive the Merger Consideration for such vested RSUs. F2: As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Common Stock. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.63 · Expires 2025-11-27 | Direct | 0 |
Reported balance
After 2025-11-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-11-19 · Disposition to issuer · Disposed 45,073 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.00 · Expires 2026-11-26 | Direct | 0 |
Reported balance
After 2025-11-19 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-11-19 · Disposition to issuer · Disposed 62,674 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.93 · Expires 2028-11-30 | Direct | 0 |
Reported balance
After 2025-11-19 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-11-19 · Disposition to issuer · Disposed 73,349 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.13 · Expires 2029-11-30 | Direct | 0 |
Reported balance
After 2025-11-19 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-11-19 · Disposition to issuer · Disposed 84,669 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.64 · Expires 2030-12-04 | Direct | 0 |
Reported balance
After 2025-11-19 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-11-19 · Disposition to issuer · Disposed 89,127 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings. |
| Employee Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.44 · Expires 2027-11-30 | Direct | 0 |
Reported balance
After 2025-11-19 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-11-19 · Disposition to issuer · Disposed 74,515 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to that certain Merger Agreement, dated as of May 28, 2024, by and among the Surmodics, Inc. (the "Issuer"), BCE Parent, LLC, ("Parent"), and BCE Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.05 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $43.00 per share in cash, without interest and subject to any applicable tax withholdings (the "Merger Consideration"). All outstanding restricted stock units ("RSUs") held by the reporting person vested immediately prior to the Effective Time and the reporting person is entitled to receive the Merger Consideration for such vested RSUs.
F2: As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Common Stock.
F3: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2025 Filed Nov 19, 2025 18:03 UTC | SURMODICS INC SRDX · Entity 72915 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 89,127 | $0.00 Strike: $33.64 | $0.00 |
DisclosureSEC source: 0001193125-25-288424 · ownership.xml · derivative · entry 7 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,127 shares Expires 2030-12-04 F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings. Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 18:03 UTC | SURMODICS INC SRDX · Entity 72915 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 84,669 | $0.00 Strike: $36.13 | $0.00 |
DisclosureSEC source: 0001193125-25-288424 · ownership.xml · derivative · entry 6 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,669 shares Expires 2029-11-30 F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings. Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 18:03 UTC | SURMODICS INC SRDX · Entity 72915 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 73,349 | $0.00 Strike: $43.93 | $0.00 |
DisclosureSEC source: 0001193125-25-288424 · ownership.xml · derivative · entry 5 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 73,349 shares Expires 2028-11-30 F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings. Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 18:03 UTC | SURMODICS INC SRDX · Entity 72915 | Disposition to issuerEmployee Stock Options (right to buy) · Derivative | 74,515 | $0.00 Strike: $37.44 | $0.00 |
DisclosureSEC source: 0001193125-25-288424 · ownership.xml · derivative · entry 4 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 74,515 shares Expires 2027-11-30 F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings. Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 18:03 UTC | SURMODICS INC SRDX · Entity 72915 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 62,674 | $0.00 Strike: $42.00 | $0.00 |
DisclosureSEC source: 0001193125-25-288424 · ownership.xml · derivative · entry 3 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,674 shares Expires 2026-11-26 F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings. Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 18:03 UTC | SURMODICS INC SRDX · Entity 72915 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 45,073 | $0.00 Strike: $56.63 | $0.00 |
DisclosureSEC source: 0001193125-25-288424 · ownership.xml · derivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,073 shares Expires 2025-11-27 F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings. Read SEC document |
| November 19, 2025 Filed Nov 19, 2025 18:03 UTC | SURMODICS INC SRDX · Entity 72915 | Disposition to issuerCommon Stock | 192,056 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-288424 · ownership.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to that certain Merger Agreement, dated as of May 28, 2024, by and among the Surmodics, Inc. (the "Issuer"), BCE Parent, LLC, ("Parent"), and BCE Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.05 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $43.00 per share in cash, without interest and subject to any applicable tax withholdings (the "Merger Consideration"). All outstanding restricted stock units ("RSUs") held by the reporting person vested immediately prior to the Effective Time and the reporting person is entitled to receive the Merger Consideration for such vested RSUs. F2 · price: As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Common Stock. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 16:46 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 4,248 | $39.91 | $169,537.68 |
DisclosureSEC source: 0000950170-24-134181 · ownership.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,056 Read SEC document |
| November 30, 2024 Filed Dec 3, 2024 18:10 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 6,470 | $39.45 | $255,241.50 |
DisclosureSEC source: 0000950170-24-132959 · ownership.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,304 F1 · balance_after: Includes 192 shares acquired through the Employee Stock Purchase Plan for the phase ending on 8/31/24 Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 16:05 UTC | SURMODICS INC SRDX · Entity 72915 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 61,017 | $0.00 Strike: $33.20 | $0.00 |
DisclosureSEC source: 0000950170-24-100171 · ownership.xml · derivative · entry 3 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,017 shares Expires 2024-11-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 16:05 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 50,569 | $40.06 | $2,025,794.14 |
DisclosureSEC source: 0000950170-24-100171 · ownership.xml · nonDerivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,582 Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 16:05 UTC | SURMODICS INC SRDX · Entity 72915 | Exercise / conversionCommon Stock | 61,017 | $33.20 | $2,025,764.40 |
DisclosureSEC source: 0000950170-24-100171 · ownership.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,151 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 464 shares acquired through the Employee Stock Purchase Plan for the phase ending on 2/29/24. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 16:46 UTC | SURMODICS INC SRDX · Entity 72915 | GrantEmployee Stock Option (right to buy) · Derivative | 89,127 | $0.00 Strike: $33.64 | $0.00 |
DisclosureSEC source: 0001209191-23-057622 · doc4.xml · derivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,127 Underlying: Common Stock · 89,127 shares Expires 2030-12-04 F1 · derivative.exercise_date: The award vests in four equal installments on each of the first four anniversaries of the December 4, 2023 grant date. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 16:46 UTC | SURMODICS INC SRDX · Entity 72915 | GrantCommon Stock | 27,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-057622 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,670 Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 17:09 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 3,703 | $32.82 | $121,532.46 |
DisclosureSEC source: 0001209191-23-057265 · doc4.xml · nonDerivative · entry 3 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,728 Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 17:09 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 2,768 | $32.82 | $90,845.76 |
DisclosureSEC source: 0001209191-23-057265 · doc4.xml · nonDerivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,431 Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 17:09 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 2,639 | $32.82 | $86,611.98 |
DisclosureSEC source: 0001209191-23-057265 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,199 F1 · balance_after: Includes 647 shares acquired through the Employee Stock Purchase Plan for the phase ending on 2/28/23 and 127 shares acquired for the phase ending on 8/31/23 . Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 18:50 UTC | SURMODICS INC SRDX · Entity 72915 | GrantEmployee Stock Option (right to buy) · Derivative | 84,669 | $0.00 Strike: $36.13 | $0.00 |
DisclosureSEC source: 0001209191-22-059495 · doc4.xml · derivative · entry 4 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,669 Underlying: Common Stock · 84,669 shares Expires 2029-11-30 F1 · derivative.exercise_date: The award vests in four equal installments on each of the first four anniversaries of the November 30, 2022 grant date. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 18:50 UTC | SURMODICS INC SRDX · Entity 72915 | GrantCommon Stock | 24,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059495 · doc4.xml · nonDerivative · entry 3 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,064 Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 18:50 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 2,768 | $36.13 | $100,007.84 |
DisclosureSEC source: 0001209191-22-059495 · doc4.xml · nonDerivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,708 Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 18:50 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 2,639 | $36.13 | $95,347.07 |
DisclosureSEC source: 0001209191-22-059495 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,476 Read SEC document |
| November 25, 2022 Filed Nov 29, 2022 17:35 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 2,172 | $36.02 | $78,235.44 |
DisclosureSEC source: 0001209191-22-058983 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,115 F1 · balance_after: Includes 246 shares acquired through the Employee Stock Purchase Plan for the phase ending 8/31/22. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 17:31 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 100 | $45.55 | $4,555.00 |
DisclosureSEC source: 0001209191-22-023199 · doc4.xml · nonDerivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,041 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 17:31 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 3,900 | $44.97 | $175,399.38 |
DisclosureSEC source: 0001209191-22-023199 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,141 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. F2 · price: Reflects the weighted average price of 3,900 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on April 1, 2022 with sale prices ranging from $44.49 to $45.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 308 shares acquired through the Employee Stock Purchase Plan for the phase ending 2/28/22. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 15:07 UTC | SURMODICS INC SRDX · Entity 72915 | GrantEmployee Stock Option (right to buy) · Derivative | 73,349 | $0.00 Strike: $43.93 | $0.00 |
DisclosureSEC source: 0001209191-21-067517 · doc4.xml · derivative · entry 3 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,349 Underlying: Common Stock · 73,349 shares Expires 2028-11-30 F1 · derivative.exercise_date: The award vests in four equal installments on each of the first four anniversaries of the November 30, 2021 grant date. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 15:07 UTC | SURMODICS INC SRDX · Entity 72915 | GrantCommon Stock | 18,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-067517 · doc4.xml · nonDerivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,733 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 15:07 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 2,639 | $43.93 | $115,931.27 |
DisclosureSEC source: 0001209191-21-067517 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,523 Read SEC document |
| November 27, 2021 Filed Nov 29, 2021 16:29 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 1,477 | $45.77 | $67,602.29 |
DisclosureSEC source: 0001209191-21-066992 · doc4.xml · nonDerivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,162 Read SEC document |
| November 25, 2021 Filed Nov 29, 2021 16:29 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 2,172 | $47.85 | $103,930.20 |
DisclosureSEC source: 0001209191-21-066992 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,639 Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 17:49 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 200 | $55.25 | $11,049.00 |
DisclosureSEC source: 0001209191-21-062477 · doc4.xml · nonDerivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,811 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. F3 · price: Reflects the weighted average price of 200 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on November 1, 2021 with sale prices ranging from $55.23 to $55.26 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 17:49 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 5,800 | $54.63 | $316,855.16 |
DisclosureSEC source: 0001209191-21-062477 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,011 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. F2 · price: Reflects the weighted average price of 5,800 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on November 1, 2021 with sale prices ranging from $54.23 to $55.17 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:01 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 500 | $56.53 | $28,266.50 |
DisclosureSEC source: 0001209191-21-059344 · doc4.xml · nonDerivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,811 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. F3 · price: Reflects the weighted average price of 500 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on October 1, 2021 with sale prices ranging from $56.45 to $56.59 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:01 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 5,500 | $55.97 | $307,830.60 |
DisclosureSEC source: 0001209191-21-059344 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,311 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. F2 · price: Reflects the weighted average price of 5,500 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on October 1, 2021 with sale prices ranging from $55.415 to $56.39 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:04 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 4,970 | $57.34 | $284,976.32 |
DisclosureSEC source: 0001209191-21-056609 · doc4.xml · nonDerivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,811 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. F4 · price: Reflects the weighted average price of 4,970 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on September 15, 2021 with sale prices ranging from $57.16 to $57.57 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:04 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 1,030 | $56.68 | $58,382.87 |
DisclosureSEC source: 0001209191-21-056609 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,781 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021. F2 · price: Reflects the weighted average price of 1,030 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on September 15, 2021 with sale prices ranging from $56.13 to $57.12 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 98 shares acquired through the Employee Stock Purchase Plan for the phase ending August 31, 2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 18:12 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 999 | $52.67 | $52,620.43 |
DisclosureSEC source: 0001209191-21-017200 · doc4.xml · nonDerivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,713 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020. F4 · price: Reflects the weighted average price of 999 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on March 1, 2021 with sale prices ranging from $52.52 to $52.92 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 18:12 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 3,001 | $51.86 | $155,638.76 |
DisclosureSEC source: 0001209191-21-017200 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,712 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020. F2 · price: Reflects the weighted average price of 3,001 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on March 1, 2021 with sale prices ranging from $51.50 to $52.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 459 shares acquired through the Employee Stock Purchase Plan for the phase ending 02/26/2021. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 16:52 UTC | SURMODICS INC SRDX · Entity 72915 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 44,779 | $0.00 Strike: $23.95 | $0.00 |
DisclosureSEC source: 0001209191-21-010801 · doc4.xml · derivative · entry 7 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,779 shares Expires 2023-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 16:52 UTC | SURMODICS INC SRDX · Entity 72915 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 27,174 | $0.00 Strike: $20.25 | $0.00 |
DisclosureSEC source: 0001209191-21-010801 · doc4.xml · derivative · entry 6 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,174 shares Expires 2022-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 16:52 UTC | SURMODICS INC SRDX · Entity 72915 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,311 | $0.00 Strike: $21.03 | $0.00 |
DisclosureSEC source: 0001209191-21-010801 · doc4.xml · derivative · entry 5 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,311 shares Expires 2021-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 16:52 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 56,152 | $53.86 | $3,024,346.72 |
DisclosureSEC source: 0001209191-21-010801 · doc4.xml · nonDerivative · entry 4 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,254 Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 16:52 UTC | SURMODICS INC SRDX · Entity 72915 | Exercise / conversionCommon Stock | 44,779 | $23.95 | $1,072,457.05 |
DisclosureSEC source: 0001209191-21-010801 · doc4.xml · nonDerivative · entry 3 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 16:52 UTC | SURMODICS INC SRDX · Entity 72915 | Exercise / conversionCommon Stock | 27,174 | $20.25 | $550,273.50 |
DisclosureSEC source: 0001209191-21-010801 · doc4.xml · nonDerivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,627 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2021 Filed Feb 16, 2021 16:52 UTC | SURMODICS INC SRDX · Entity 72915 | Exercise / conversionCommon Stock | 10,311 | $21.03 | $216,840.33 |
DisclosureSEC source: 0001209191-21-010801 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 16:14 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 157 | $45.54 | $7,149.78 |
DisclosureSEC source: 0001209191-21-007223 · doc4.xml · nonDerivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,142 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 16:14 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 2,843 | $44.77 | $127,273.15 |
DisclosureSEC source: 0001209191-21-007223 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,299 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020. F2 · price: Reflects the weighted average price of 2,843 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 1, 2021 with sale prices ranging from $44.50 to $45.38 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:25 UTC | SURMODICS INC SRDX · Entity 72915 | SaleCommon Stock | 2,000 | $43.96 | $87,925.60 |
DisclosureSEC source: 0001209191-21-002066 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,142 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2020. F2 · price: Reflects the weighted average price of 2,000 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on January 4, 2021 with sale prices ranging from $43.485 to $44.24 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 17:12 UTC | SURMODICS INC SRDX · Entity 72915 | GrantEmployee Stock Option (right to buy) · Derivative | 74,515 | $0.00 Strike: $37.44 | $0.00 |
DisclosureSEC source: 0001209191-20-061225 · doc4.xml · derivative · entry 2 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,515 Underlying: Common Stock · 74,515 shares Expires 2027-11-30 F1 · derivative.exercise_date: The award vests in four equal installments on each of the first four anniversaries of the November 30, 2020 grant date. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 17:12 UTC | SURMODICS INC SRDX · Entity 72915 | GrantCommon Stock | 17,361 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-061225 · doc4.xml · nonDerivative · entry 1 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,142 Read SEC document |
| November 28, 2020 Filed Nov 30, 2020 19:19 UTC | SURMODICS INC SRDX · Entity 72915 | Tax withholdingCommon Stock | 1,969 | $38.36 | $75,530.84 |
DisclosureSEC source: 0001209191-20-060803 · doc4.xml · nonDerivative · entry 3 Maharaj Gary R · CIK 0001508798 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,781 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.